Clinical Trials · NCT06548490
GLP-1R Agonist Treatment for Opioid Use Disorder
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Milton S. Hershey Medical Center
- Enrollment
- 200
- Start date
- Jan 2025
- Locations
- 3 sites, United States
- Primary endpoint
- Number of participants being abstinent from illicit and nonprescribed opioids.